NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Thursday:
Moderna Inc., up $7.27 to $85.87.
The vaccine maker gave investors an encouraging update on a potential cancer vaccine being developed with Merck.
Glaukos Corp., up $15.32 to $75.74.
The glaucoma treatments developer received regulatory approval in the U.S. of its eye-condition drug iDose.
Jabil Inc., up $15.82 to $136.42.
The electronics manufacturer beat analysts' fiscal first-quarter earnings and revenue forecasts.
Rivian Automotive Inc., up $2.75 to $22.43.
AT&T will buy vehicles for its fleet from the electric vehicle maker.
Apellis Pharmaceuticals Inc., down $10.70 to $52.18.
The biopharmaceutical company warned investors about the potential for a negative opinion on an eye condition drug from European regulators.
Adobe Inc., down $39.62 to $584.64.
The software company's profit forecast for its current fiscal year disappointed investors.
Hess Corp., up $6.37 to $143.10.
Energy stocks gained ground along with rising crude oil prices.
Newmont Corp., up $1.15 to $41.15.
The gold producer rose along with prices for the precious metal.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
